THE VENOUS THROMBOTIC RISK IN NONSURGICAL PATIENTS - EPIDEMIOLOGIC DATA AND EFFICACY SAFETY PROFILE OF A LOW-MOLECULAR-WEIGHT HEPARIN (ENOXAPARIN)

Authors
LECHLER E SCHRAMM W FLOSBACH CW BERGEMANN W BROCKHAUS W EGBRING R GARBOR M GEIDEL H HENGSTMANN JH JAGER K KELLER F LENZ K LUDWIG M MAURIN NJA NIESSNER H PICKLPFEFFER S PLATT D SCHAUER J SCHENTKE KU SCHULZ J SLANY J TEUFEL J HALBRITTER R THIELE G THIER WH TREESE N WAGNER T
Citation
E. Lechler et al., THE VENOUS THROMBOTIC RISK IN NONSURGICAL PATIENTS - EPIDEMIOLOGIC DATA AND EFFICACY SAFETY PROFILE OF A LOW-MOLECULAR-WEIGHT HEPARIN (ENOXAPARIN), Haemostasis, 26, 1996, pp. 49-56
Citations number
23
Categorie Soggetti
Hematology
Journal title
Haemostasis → ACNP
ISSN journal
03010147
Volume
26
Year of publication
1996
Supplement
2
Pages
49 - 56
Database
ISI
SICI code
0301-0147(1996)26:<49:TVTRIN>2.0.ZU;2-V
Abstract
In a multicentre, randomized, double-blind controlled trial comparing the low-molecular-weight heparin enoxaparin (40 mg) with a standard un fractionated heparin (Ca-heparin, 3 x 5,000 U) in deep-vein thrombosis prophylaxis in a highrisk group of 959 hospitalized medical patients, enoxaparin was at least as efficacious as standard heparin, with fewe r adverse events.